How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
Extract from report of GACVS meeting of 29-30 November 2006, published in the WHO Weekly Epidemiological Record of 19 January 2007
Vaksen Kont Epatit AKi Sa Ou Bezwen Konnen
Swissmedic explique le fonctionnement d'un vaccin à vecteur dans le cadre campagne d’information de l'OFSP sur la vaccination contre le Covid-19. Plus d'infos sur https://ofsp-coronavirus.ch/vaccination
Swissmedic explique le fonctionnement d’un vaccin à ARNm dans le cadre campagne d’information de l'OFSP sur la vaccination contre le Covid-19. Plus d'infos sur https://ofsp-coronavirus.ch/vaccination
In this unit we will learn about vaccines and what is the progress made for developing a vaccine for COVID-19
Jesuit Worldwide Learning invites you to learn facts and test your knowledge on the ongoing pandemic caused by Coronavirus (COVID 19) through a fun-interactive crash course! Access is free!... You have only to sign up
more
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
more
The Virtual cGMP Training Marathon for Vaccine Manufacturing: Principles into Practice took place from 12 Sep to 10 Oct 2023 to continue to provide manufacturers & regulators with a comprehensive array of topics to build understanding of current WHO & international GMP standards, technological advan...cements, industry practices and regulatory expectations specific to the vaccine manufacturing context. Some of the topics include computer system validation, data integrity, challenges in lyophilization and others. Real world examples and case studies will be used to show how to interpret current and recently new good manufacturing practices requirements from a practical point of view and to implement appropriate approaches.
more
The immunization program has been going well until a rumor begins that one child in a community far from the capital has become sick after receiving a vaccine. The rumor is becoming stronger every day and is picking up coverage on local radio.
Concerned that the rumor might make caregivers concer...ned about bringing their children for vaccination, a few frontline workers (FLWs) go to the house of the children who fell sick. They find out from the child's mother that she never thought her son was sick due to the vaccination he received. The mother agrees to speak to other caregivers during a community gathering to explain that her son's illness was not caused by his vaccination. She also responds to a few questions to reassure other caregivers about the safety and advantages of immunization.
more
first issued 18 August 2022
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...cial disruption and economic consequences of COVID-19, curtail the emergence of new SARS-CoV-2 variants of concern (VOCs) and ultimately control the pandemic.
more
Learn about the first Malaria vaccine. Who should receive this vaccine? What are the challenges of rolling out a Malaria vaccine in the midst of a pandemic? Dr Pedro Alonso explains in Science in 5 this week.
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
Overview
The aim of this guide is to support national immunization programme managers and others responsible for implementing human rabies vaccine programmes to:
inform policy discussions and operational planning for introducing or expanding rabies post-exposure prophylaxis (PEP) into a nationa...l immunization programme (e.g. through the national immunization programme, or other programmes); and
highlight considerations specific to rabies PEP for integration into existing systems, including for implementation, and monitoring and evaluation.
While the guide is mainly intended for programme managers and focuses on human vaccination, complementary animal health measures are highlighted where relevant given the zoonotic nature of rabies.
The guide was developed collaboratively with input from technical experts in rabies and immunization, vaccines and biologicals.
more